Articles published by GlobeNewswire
From Olema Oncology
Via GlobeNewswire
Tickers
OLMA
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
Via GlobeNewswire
Tickers
TEVA
Ingersoll Rand Expands Life Sciences Capabilities with Acquisition of Scinomix, Inc.
January 05, 2026
From Ingersoll Rand
Via GlobeNewswire
Tickers
IR
Teladoc Health to Participate in Upcoming Investor Conference
January 05, 2026
From Teladoc Health, Inc.
Via GlobeNewswire
Tickers
TDOC
Root, Inc. to Participate in the 28th Annual ICR Conference
January 05, 2026
From Root, Inc.
Via GlobeNewswire
Tickers
ROOT
Via GlobeNewswire
Tickers
VST
Mobix Labs, Inc. Announces Proposed Public Offering of Common Stock
January 05, 2026
From Mobix Labs, Inc.
Via GlobeNewswire
Tickers
MOBX
Jefferson Capital Announces Launch of Secondary Public Offering and Concurrent Share Repurchase
January 05, 2026
From Jefferson Capital
Via GlobeNewswire
Tickers
JCAP
Enovis Appoints Oliver Engert as Chief Administrative Officer
January 05, 2026
From Enovis Corporation
Via GlobeNewswire
Tickers
ENOV
Via GlobeNewswire
Tickers
MYGN
Lands' End Announces Participation in the 28th Annual ICR Conference
January 05, 2026
From Lands' End, Inc.
Via GlobeNewswire
Tickers
LE
KALA BIO Settles Approximately $10.6 million of Debt
January 05, 2026
From KALA BIO, Inc.
Via GlobeNewswire
Tickers
KALA
AVITA Medical Announces Changes to its Board of Directors
January 05, 2026
From AVITA Medical
Via GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2026
Via GlobeNewswire
Tickers
FATE
Zscaler Appoints Sunil Frida as Chief Marketing Officer to Drive Next Phase of Global Growth
January 05, 2026
From Zscaler, Inc.
Via GlobeNewswire
Tickers
ZS
From Outset Medical, Inc.
Via GlobeNewswire
Tickers
OM
Silvaco To Present at the 28th Annual Needham Growth Conference
January 05, 2026
From Silvaco
Via GlobeNewswire
Tickers
SVCO
From Heartflow, Inc.
Via GlobeNewswire
Tickers
HTFL
Via GlobeNewswire
Tickers
CRNX
Via GlobeNewswire
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
January 05, 2026
From Galapagos NV
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.